GI - stomach acid crap Flashcards
1
Q
H2 receptor Antagonists
A
Cimetidine, Ranitidine (ZANTAC), Famotidine (PEPCID), Nizatidine (AXID)
2
Q
H2 receptor antagonists
A
- antagonize H2 receptors (dec cAMP production, and dec production and dec the activity of the H+/K+ ATP-ase
- Indications:
- used for gastric, and duodenal ulcers
- adjunts to gastoesophageal reflux
- tx zollinger ellison syndrome
- tx nocturnal acid secretion
- given pre-op to dec the acid content of the stomach
- prevent development of ulcers in response to stress
- tx severe allergic reactions (dec H2 mediated vasodilation in conjunction with H1 antagonists)
- High doses of cimetidine can be used to tx masculinization (at high doses cimetidine is anti-androgenic) - metabolized by the liver
- cimetidine, ranititinde, and famotidine have injectable forms - SE
- HA, dizziness, nausea, myalgia, itching, rash- seen in elderly pts with impaired renal function
- chronic cimetidine- with high doses: anti-androgen - loss of libido, impotence, and gynecomastia - Drug Interactions
- Cimetidine inhibits CYP3A4- therefore dec. metabolism of warfarin, phenytoin, etc. (see list on ho pg. 6)
- Other H2 inhibitors do not inhibit CYP34A
- alteration of the gastric pH may alter bioavailability of drugs that are absorbed at a low ph
3
Q
Proton pump inhibitors (drug list)
A
Omeprazole (PRILOSEC), esomeprazole (nexium), lansoprazole (PREVACID), rabeprazole (aciphex), pantoprazole (PROTONIX)
4
Q
Proton Pump Inhibitors
A
- irreversibly inhibit the proton pump the final stage of acid production by binding to the H+/K+ ATP-ase in the parietal cell
- Indications
- DOC for GERD (administer for a minimum of 1-2 months for tx, maintenance of GERD)
- Tx for gastric and duodenal ulcers and prevent development of ulcers in ppl using NSAIDs
- high doses tx zollinger ellison syndrome - Prodrugs- administered in the inactive form- which is highly lipophilic- activated in the parietal cells to the active sulfenamide in the presence of gastric acid- become trapped in the cell (irreversible)
- effect lasts 24-48hrs and takes 2-5days to produce a significant effect
- take on an empty stomach
- metabolized in the liver microsomal enzymes - SE
- nausea, vomiting, diarrhea, abdominal colic
- dec. absorption of calcium: osteoporosis
- dec absorption of mg: hypomagnesemia- muscle spasms
- inc. cough and URI esp pneumonia,
- potential for bacterial overgrowth with long term use (bc of change in pH) - Drug interactions
- omeprazole (prilosec)- inhibits CYP2C19- dec met. of phenytoin, cyclosporine, diazepam, and warfarin
- omeprazole inhibits conversion of clopidrogel to action compound
- All other PPI: warfarin interaction
5
Q
Sucralfate
A
- cyroprotective agent- Al salt of sulfated sucrose-
- Indications
- form protective barrier on the epithelium and exposed proteins in the crater of a stomach ulcer - Most effective when taken before meals
- SE
- constipation, dry mouth, abdominal discomfort - Drug interactions
- inc absorption of digitalis, tetracycline, and phenytoin
- avoid antacids 1hr before and after taking sucralfate
6
Q
Misprostol
A
- Cytoprotective Agents - prostaglandins E1 analogue- inc secretion of mucus, decreases acid secretion
- used to prevent ulceration induced by NSAID’s
- used in conjunction with dinoprostone to induce abortions - SE
- diarrhea, abdominal distress, headache, and dizziness
7
Q
Antimicrobial agents and tx of peptic ulcer
A
- specifically tx against helibacter pylori drugs: metridonazole, amoxicillin, tetracycline, and clarithromycin
antibiotic and anti-ulcer drugs combo paks: helidac, tritec